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Abstract: Subacute sclerosing panencephalitis (SSPE) is a rare progressive neurological disorder
of early adolescence caused by persistent infection of the measles virus, which remains prevalent
worldwide despite an effective vaccine. SSPE is a devastating disease with a characteristic clinical
course in subcortical white matter; however, atypical presentations of brainstem involvement may
be seen in rare cases. This review summarizes reports to date on brainstem involvement in SSPE,
including the clinical course of disease, neuroimaging presentations, and guidelines for treatment.
A comprehensive literature search was performed for English-language publications with keywords
“subacute sclerosing panencephalitis” and “brainstem” using the National Library of Medicine
PubMed database (March 1981–September 2017). Eleven articles focusing on SSPE of the brainstem
were included. Predominant brainstem involvement remains uncharacteristic of SSPE, which may
lead to misdiagnosis and poor outcome. A number of case reports have demonstrated brainstem
involvement associated with other intracranial lesions commonly presenting in later SSPE stages
(III and IV). However, brainstem lesions can appear in all stages, independent of higher cortical
structures. The varied clinical presentations complicate diagnosis from a neuroimaging perspective.
SSPE of the brainstem is a rare but important clinical entity. It may present like canonical SSPE or
with unique clinical features such as absence seizures and pronounced ataxia. While SSPE generally
progresses to the brainstem, it can also begin with a primary focus of infection in the brainstem.
Awareness of varied SSPE presentations can aid in early diagnosis as well as guide management
and treatment.
Keywords: brainstem; measles; neurodegeneration; neuroimaging; subacute sclerosing panencephalitis
1. Introduction
Measles is a leading cause of morbidity and mortality among young children worldwide, despite
the availability of a safe and effective vaccine. During 2015, the United States experienced a multistate
measles outbreak; outbreaks such as these are generally related to transmission in under-immunized
communities after the disease is introduced from endemic areas [1]. The World Health Organization
(WHO) global measles case burden in 2015 was 254,928 cases across all six regions, with an estimated
134,200 deaths [2]. While the WHO reports 189,929 cases in 2016 and 93,943 cases to date in
2017, measles is widely known to be underreported [3]. Although accelerated immunizations have
significantly reduced disease burden, measles remains common in developing countries.
The measles virus is a highly contagious enveloped single-stranded negative sense virus,
transmitted via the respiratory tract from exposure to infectious aerosols. Initially, the virus
demonstrates tropism for CD150+ alveolar macrophages and dendritic cells, leading to systemic spread
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through lymphoid tissue. Both B- and T-lymphocytes can be infected, with the infection of B-cells
creating the pathognomonic syncytial Warthin-Finkeldey cells observed in the upper gastrointestinal
(GI) tract [4]. Viral particles migrate to epithelial cells through cell surface receptor nectin-4, leading to
the systemic infection in the GI tract, kidney, liver, skin, and in rare cases the central nervous system
(CNS) [5]. The rapid dissemination of measles throughout primary, secondary, and tertiary lymphoid
tissue creates an acute lymphopenic state soon after infection. This leads to an increased susceptibility
to opportunistic infections, specifically in sites that rely on tertiary lymphoid tissues, e.g., GI and
pulmonary systems [5].
Measles infection results in a systemic, febrile illness characterized by dry cough, sore throat,
muscle aches, coryza, light sensitivity, conjunctivitis, Koplik’s spots inside mouth, and maculopapular
rash. Typically, measles is self-limiting; however, measles may result in infrequent complications
involving the CNS. Acute disseminated encephalomyelitis and measles inclusion body encephalitis
are two acute-onset pathologies that can rapidly progress to coma or death. A third CNS pathology,
and the focus of this review, is subacute sclerosing panencephalitis (SSPE) [2].
SSPE is a fatal long-term complication of measles infection, caused by the intracerebral spread
of the measles virus leading to neuronal destruction. The incidence of SSPE ranges from 4–11 per
100,000 cases of measles in the U.S. and 23 per 100,000 cases in Israel [6]. Rates among children under
one year of age can be up to 18 times higher than children over the age five years, presumably due to
immune system immaturity [6]. The latency period between acute measles and the first symptoms of
SSPE is usually 4 to 10 years, but can range from one month to 27 years [7]. Most patients survive for
one to three years after diagnosis, with a mean survival of about 18 months [8]. Effective treatment
remains elusive, and immunization is the only present solution to prevent SSPE [7]. Although canonical
SSPE predominantly affects the frontal and temporal lobes, rhombencephalitis due to SSPE affecting
the brainstem presents with atypical clinical and imaging findings. The aim of this review is to
provide a summary of clinical, neurobiological, semiological, and imaging findings in SSPE with
brainstem involvement.
2. Methods
The literature search was performed using the National Library of Medicine PubMed database.
We included all English-language publications with keywords “subacute sclerosing panencephalitis”
and “brainstem” in the title or abstract. This search yielded 15 unique articles. Three study authors
(P.S.U., J.K.Y., J.Y.) independently reviewed each article and associated references to determine their
relevance to SSPE, indications for brainstem involvement, clinical and neuroimaging presentations, or
guidelines for treatment. Two additional articles were included from references. Any discrepancies for
determining article inclusion/exclusion were adjudicated by the senior author (J.D.C.).
Of the 17 articles, six were excluded due to inapplicability to the focus of the current study (one
studied non-human primates, two lacked focus on brainstem, three were not accessible). A final total
of 11 manuscripts were included in the current review.
3. Results
SSPE is thought to progress through four distinct stages. Stage I includes personality changes and
behavior disturbance. Stage II shows stereotyped myoclonic muscle contractions, poor coordination,
choreoathetosis, tremors, and convulsive motor signs. Stage III is characterized by coma, opisthotonus,
decerebrate rigidity, and dystonia. Stage IV progresses to loss of cerebral cortex function, less frequent
myoclonus, diminished hypertonia, and eventually death. This presentation is consistent with
virus-mediated neuronal destruction of the telencephalon (i.e., occipital, parietal, and frontal lobes)
causing personality and cognitive changes in stage I to viral infiltration of the rhombencephalon in the
later stages, eventually causing stupor, coma, and death [9,10]. In accordance with these disease stages,
a diagnosis of SSPE is based on characteristic clinical signs and symptoms including personality changes,
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gradual mental deterioration, and myoclonus, coupled with periodic electroencephalogram (EEG) activity
and elevated anti-measles immunoglobulin G (IgG) in serum and cerebrospinal fluid (CSF).
Cece et al. describe a study of 76 patients from Turkey with SSPE. Of these, 6.6% received a measles
vaccine. Magnetic resonance imaging (MRI) findings most consistently showed signal alteration in
the frontal (25.0%), parietal (18.4%), and occipital (15.8%) lobes. Brainstem involvement was only
seen in one patient presenting at disease stage II. As such, predominant brainstem involvement is not
characteristic of SSPE and can lead to confusion surrounding diagnosis [9]. This progression from
cortical structures down to the midbrain is described by Alkan et al. through a case-control study of
18 patients with stage II (N = 11) and III (N = 7) SSPE and 11 age-matched controls who underwent
MRI and diffusion-weighted imaging. MRI of one stage II and five stage III patients revealed brainstem
involvement and cerebral atrophy. Neuronal loss, demyelination, and gliosis led to an expansion of
extracellular space, as shown by the significant increase in the apparent diffusion coefficient values of
the brainstem in patients compared to controls [10]. A case series of 26 SSPE patients by Anlar et al.
also showed brainstem involvement in two stage III patients, with associated periventricular white
matter and subcortical white matter lesions [11]. Several case reports, however, demonstrated atypical
presentations of SSPE with predominant brainstem involvement.
Sharma et al. describe one such case report of a 15-year-old male patient with gradual decline
in academic function and new onset generalized tonic-clonic seizures. MRI showed brainstem T2
hyperintensities in the pons and middle cerebellar peduncles. Given the patient’s classic clinical
presentation, SSPE was diagnosed and CSF titers confirmed measles titer of 1:512. The authors here
stressed the importance of understanding that SSPE can present with brainstem lesions without the
involvement of higher cortical structures [12].
Jayakumar et al. describe a series of 15 cases of SSPE, six of whom presented in stage III. Two of
these six showed selective atrophy of brainstem on computed tomography (CT) scans with normal
cerebral hemispheres. Prior to this case series, brainstem atrophy in late stage disease was thought
to be secondary to cerebral atrophy. These CT findings support the idea that imaging pathology is
secondary to primary infection by measles virus [13].
The importance of early SSPE diagnosis in brainstem cases is highlighted by Saini et al. in the case
of a five-year-old male patient who developed acute onset cerebellar ataxia without focal neurological
deficits. MRI showed brainstem lesions involving the pons and cerebellum. Clinical suspicion for an
acute demyelinating disease was high and the patient was started on intravenous methylprednisolone
at a dose of 30 mg/kg/day. After a brief period of clinical improvement (two to three days), the
patient developed myoclonic jerks suspicious for SSPE. This patient had brainstem involvement in
stage I of diagnosis. SSPE diagnosis was confirmed on CSF analysis with a measles titer of 1:625 and
on EEG that demonstrated stereotyped periodic time-locked complexes consistent with myoclonic
jerks [14]. Corticosteroids were avoided due to the risk of complications for a clinically-isolated
demyelinating syndrome; in general, steroids have not been beneficial in SSPE and can lead to rapid
clinical deterioration [14]. Yaramis and Tas¸kesen also describe a case of SSPE showing early brainstem
involvement characterized by a truncated clinical course and early progression to death. The case was
of a 7-year-old boy who presented with severe stage II clinical signs, and his MRI showed lesions in the
pons and middle cerebellar peduncles. Hence, early brainstem involvement may designate worsened
prognosis in SSPE [8].
The pattern of brainstem involvement in MRI can increase suspicion for SSPE versus other
CNS pathologies. Sener describes a case of a 11-year-old presenting with seizures and ataxia nine
years after measles infection. Diffusion MRI showed prominent pontine involvement with extension
into the midbrain and middle cerebellar peduncle, as well as high signal intensity in the ventral
pons. The ventral pons contains corticopontine, corticonuclear, and corticospinal fibers that connect
with the cerebral cortex. The dorsal pontine tegmentum, in contrast, is connected to the medulla
oblongata [15]. Senol et al. also describe two more cases where T2 MRI showed diffuse involvement of
the mesencephalon and pons with sparing of the pontine tegmentum [16].
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It is possible for imaging findings to be misleading. Yilmaz et al. describe two cases with
early brainstem involvement, the second of which was MRI negative on presentation. This case of
a six-year-old female patient was clinically classical. She had frequent myoclonic jerks with EEG,
demonstrating periodic high amplitude slow wave bursts. At the six-month follow-up, her MRI
showed hyperintense lesions in the pons and cerebellar peduncles [17]. Yaramis and Tas¸kesen also
describe two cases of SSPE showing early brainstem involvement, with one case presenting normal
MRI findings upon admission. The case was of a 12-year-old male with clinical symptoms of drop
attacks and myoclonic jerks. EEG examination detected 1–3 Hz periodic and bilateral high altitude
sharp and slow-wave complexes. The disease progressed rapidly, however, and MRI imaging showed
lesions in the brainstem after five months [8].
As described above, EEG findings in SSPE are characteristic and generally include spike-and-wave
complexes with 1–3 Hz oscillation. Ishikawa et al. describe a case report of a 10-year-old female patient
with a five-month history of absence seizures. Her ictal EEG showed characteristic spike-and-wave
complexes followed by 2.5 Hz desynchronization during absence attacks, suggesting lesion origination
in the brainstem [18]. This case further describes the varied presentations of SSPE, as seen by absence
seizures with mixed SSPE and seizure semiology, from both imaging and EEG perspectives.
4. Discussion
Globally, the incidence of measles infections is declining due to aggressive vaccination efforts.
In the U.S., measles outbreaks within the last three years can be in part attributed to medical
contraindications to vaccinations, travelers from endemic regions outside the U.S., and/or missed
vaccination opportunities. Given the potential long-term sequelae of measles infections, effective
diagnosis of SSPE is exceedingly important in light of recent events. Our review covers the breadth of
literature on the atypical entity of SSPE of the brainstem. By informing clinical judgment and imaging
analysis, our goal is to ensure that no cases of SSPE are misdiagnosed, as mortality can range from
50–95% [19,20].
Typically, SSPE progresses through its four stages starting with lesions in the higher cerebral
cortices and working its way down to the brainstem. Lesions of the frontal, parietal, and occipital
lobes correlate with symptomatology of diminished academic performance, mood dysregulation, and
cortical blindness, among others. Although brainstem atrophy is commonly seen as SSPE progresses
to stage IV disease, primary lesions noted as MRI hyperintensities at earlier disease stages are rare,
with an incidence of roughly 7.6% [11]. Primary brainstem lesions with no associated cortical lesions
are even rarer and data is confined to a few case reports [15–17]. Primary brainstem lesions are
historically suggestive of autoimmune (i.e., autoimmune disseminated encephalomyelitis, multiple
sclerosis) or metabolic demyelinating diseases (i.e., osmotic demyelination syndrome) [21]. Importantly,
the aforementioned case reports argue against the exclusion of SSPE in the differential diagnosis of
primary brainstem lesions. A summary of findings related to SSPE with brainstem lesions, as seen
in Table 1, highlights a few important factors. First, although MRI is a valuable diagnostic tool, few
patients will have clinical signs and no imaging findings. Diffusion weighted imaging, however,
seems to offer greater diagnostic sensitivity with significant differences seen between SSPE patients
and controls. When working through a complicated neurological differential, clinical presentation,
imaging, and EEG findings are critical.
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Table 1. Summary of included studies.
Case Reports
Author Demographics Presentation EEG Imaging Findings Treatments
Saini et al. [14] 5-year-old male
Cerebellar ataxia without focal motor
deficits or cognitive decline preceded by
vesicular, pruritic truncal rash.
Anti-measles titers 1:625
Periodic complexes
time-locked with
myoclonus
Pontine and cerebellar lesions
suggestive of demyelination
Methylpredni-solone
30 mg/kg/day for
five days
Sharma et al. [12] 15-year-old male
Tonic-clonic seizure with increasing
frequency and gradual decline in school
performance
Periodic generalized
high-amplitude sharp and
slow wave of 1–2 s
Hyperintensities in pontine
and middle cerebellar regions
on T2 and T2 FLAIR, with
frontotemporal atrophy
Intrathecal IFN-α,
valproate, clonazepam
Yilmaz et al. [17] 9-year-old female and6-year-old female
Both patients presented with typical
SSPE including mental deterioration
and myoclonus
Not reported
nine-year-old: 2 cm × 2.5 cm
focal pontine lesion on T2 MRI;
six-year-old: hyperintense
pontine and cerebellar
peduncular lesions on T2 MRI
Not reported
Sener [15] 11-year-old male Not reported Not reported
DWI showing prominent
pontine involvement with
sparing of tegmentum and
longitudinal nerve bundles
Not reported
Ishikawa et al. [18] 10-year-old female Atypical absence seizures forthree months
Diffuse spike and wave
complexes of 2.5 Hz with
desynchronization during
absence attacks
Not reported Not reported
Case Series and Reviews
Author Description Results Imaging Findings
Alkan et al. [10] 18 SSPE patients 10controls with MRI/DWI
33% of SSPE patients had brainstem
involvement; greater proportion of
Stage III SSPE had brainstem
involvement compared to Stage II
(71.4% vs. 9.0%); increased ADC values
were associated with disease stage
ADC values in SSPE patients across seven regions (frontal, parietooccipital, cerebellar and
deep white matter, basal ganglia, thalamus, and brainstem) were significantly increased
from controls, p < 0.05
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Table 1. Cont.
Case Series and Reviews
Author Description Results Imaging Findings
Jayakumar et al. [13] 15 SSPE patients with CT
Brainstem involvement in two of
15 patients; one patient with Stage III
disease had normal CT
Stage II: cerebral edema, diffuse white matter attenuation.
Stage III/IV: cerebral, cerebellar and brainstem atrophy, white matter hypodensities
Anlar et al. [11] 26 SSPE patients with T2and T2 FLAIR MRI
Lesions originated in cortical or
subcortical white matter; extent of white
matter lesions was not correlated with
neurologic status; three patients had
normal scans
T2-hyperintense lesions progressed from subcortical white matter to periventricular white
matter; basal ganglia and brainstem lesions were rare
Cece et al. [9] 76 SSPE patients withMRI
Stage I/II n = 48, stage III n = 25, stage
IV n = 3; significant subset of presented
with myoclonic seizures (57.9%) and/or
behavior alteration (30.3%)
MRI normal in 21 patients (Stage I/II n = 19); three patients had brainstem involvement
(Stage II n = 1, Stage IV n = 2); T2-hyperintense lesions were predominantly in the
periventricular and subcortical white matter
EEG: electroencephalogram; SSPE: sub-acute sclerosing pan-encephalitis; FLAIR: fluid attenuated inversion recovery; IFN-α: interferon-alpha; MRI: magnetic resonance imaging;
DWI: diffusion weighted image; ADC: apparent diffusion coefficient; CT: computed tomography.
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Notably, all cases of SSPE with pontine involvement preferentially affect the ventral pons and
middle cerebellar peduncle [15,16]. The middle cerebellar peduncle is composed of afferents of pontine
nuclei that are part of a cortico-ponto-cerebellar axis that transmits the desired positioning of body
parts in intended motor movement [22]. It stands to reason that canonical SSPE infection of cortical
structures and the predilection of SSPE for the ventral pons may both be due to a similar tropism
inherent to the measles virus. It is possible that preferential infection of white matter structures—as
seen in cortical descending fibers, basis pontis, and middle cerebellar peduncle—can explain the
pattern of SSPE lesion loci. Studies have shown the early involvement of white matter tracts through
MRI and diffusion-tensor imaging (DTI) images [23]. Although primary brainstem infections in SSPE
are seen as aberrant, they adhere to a pattern of measles virus translocation consistent with more
typical presentations.
5. Conclusions
SSPE is a rare but serious complication of measles infection. Overall, measles vaccination
is effective as first-line prevention against SSPE. Classically, SSPE affects cortical telencephalic
structures before progressing to deep brain structures. Here we summarize the literature surrounding
atypical presentation of SSPE with primary foci in the brainstem. The varied semiology and
imaging presentations are important clinically, as mortality can range from 50–95%. Clinical and
pathophysiological understanding of the atypical presentation of this clinical entity and its progression
may aid in early diagnosis and targeted treatment, and warrant further research.
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